2019
Viral RNA-dependent RNA polymerase inhibitor 7-deaza-2'-C-methyladenosine prevents death in a mouse model of West Nile virus infection
EYER, Luděk; Martina FOJTÍKOVÁ; Radim NENCKA; Ivo RUDOLF; Zdeněk HUBÁLEK et al.Základní údaje
Originální název
Viral RNA-dependent RNA polymerase inhibitor 7-deaza-2'-C-methyladenosine prevents death in a mouse model of West Nile virus infection
Autoři
Vydání
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Washington, D.C. AMER SOC MICROBIOLOGY, 2019, 0066-4804
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10606 Microbiology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.904
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14310/19:00109098
Organizační jednotka
Přírodovědecká fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
West Nile virus; antiviral agents; flavivirus; nucleoside analogs
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 3. 2020 12:03, Mgr. Marie Novosadová Šípková, DiS.
Anotace
V originále
West Nile virus (WNV) is a medically important emerging arbovirus causing serious neuroinfections in humans and against which no approved antiviral therapy is currently available. In this study, we demonstrate that 2=-C-methyl- or 4=-azido-modified nucleosides are highly effective inhibitors of WNV replication, showing nanomolar or low micromolar anti-WNV activity and negligible cytotoxicity in cell culture. One representative of C2=-methylated nucleosides, 7-deaza-2=-Cmethyladenosine, significantly protected WNV-infected mice from disease progression and mortality. Twice daily treatment at 25 mg/kg starting at the time of infection resulted in 100% survival of the mice. This compound was highly effective, even if the treatment was initiated 3 days postinfection, at the time of a peak of viremia, which resulted in a 90% survival rate. However, the antiviral effect of 7-deaza-2=-Cmethyladenosine was absent or negligible when the treatment was started 8 days postinfection (i.e., at the time of extensive brain infection). The 4=-azido moiety appears to be another important determinant for highly efficient inhibition of WNV replication in vitro. However, the strong anti-WNV effect of 4=-azidocytidine and 4=- azido-aracytidine was cell type dependent and observed predominantly in porcine kidney stable (PS) cells. The effect was much less pronounced in Vero cells. Our results indicate that 2=-C-methylated or 4=-azidated nucleosides merit further investigation as potential therapeutic agents for treating WNV infections as well as infections caused by other medically important flaviviruses.